Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential

Oncogene

Volumn 13, Issue 11, 1996, Pages 2339-2347

  Huang, Suyun ^a   Luca, Mario ^a   Gutman, Mordechai ^a   McConkey, David J ^c   Langley, Keith E ^b   Lyman, Stewart D ^b   Bar Eli, Menashe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b AMGEN INC   (United States)

^c Immunex R and D Corporation ^*

Author keywords

Apoptosis; c KIT; Melanoma; Tumor metastasis

Indexed keywords

GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN TYROSINE KINASE; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENICITY; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG METASTASIS; MALE; MELANOMA CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; ONCOGENE C KIT; PRIORITY JOURNAL; PROTO ONCOGENE;

ANIMALS; APOPTOSIS; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT; RNA, MESSENGER; SKIN NEOPLASMS; STEM CELL FACTOR; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030459095     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Abrahamson JLA, Lee JM and Bernstein A. (1995). Mol. Cell Biol., 15, 3775-3784.
2. Albelda MS, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M and Buck CA. (1990). Cancer Res., 50, 6757-6764.
3. Albino AP, Davis BM and Nanus DM. (1991). Cancer Res., 51, 4815-4820.
4. Andre C, d'Auriol L, Lacomb C, Gisselbrecht S and Galibert F. (1989). Oncogene, 4, 1047-1049.
5. Armstrong CA, Murray N, Kennedy M, Koppula SV, Tara D and Ansel JC. (1994). J. Invest. Dermatol., 102, 278-284.
6. Brannan CI, Lyman SD, Williams DE, Eisenman J, Anderson D, Cosman D, Bedell MA, Jenkins MA and Copeland NG. (1991). Proc. Natl. Acad. Sci. USA, 88, 4671-4674.
7. Caceres-Cortes J, Rajotte D, Dumouchel J, Haddad P and Hoang T. (1994). J. Biol. Chem., 269, 12084-12091.
8. Carpenter G. (1987). Ann. Rev. Biochem., 56, 881-914.
9. Chabot B, Stephenson DA, Chapman VM, Besmer P and Bernstein A. (1988). Nature, 335, 88-89.
10. Fernandez A, Fosdick LJ, Marin MC, Diaz C, McDonnell TJ, Ananthaswamy HN and McConkey DJ. (1995). Oncogene, 10, 769-774.
11. Ferrone S, Imberti L, Natali PG, Schrier P and Ruiter D. (1986). Roth JA (ed), pp. 111-139, Futura: New York.
12. Fidler IJ. (1990). Cancer Res., 50, 6130-6138.
13. Flanagan JG, Chan DG and Leder P. (1991). Cell, 64, 1025-1035.
14. Fleischman RA. (1992). J. Clin. Invest., 89, 1713-1717.
15. Fleischman RA, Saltman DL, Stastny V and Zneimer S. (1991). Proc. Natl. Acad. Sci. USA, 88, 10885-10889.
16. Fleming HG, Alpern EJ, Uchida N, Ikuta K and Weissman IL. (1993). Proc. Natl. Acad. Sci. USA, 90, 3760-3764.
17. Fort P, Marty L, Piechaczyh M, Sabrouty SE, Dani C, Jeanteur P and Blanchard JM. (1985). Nuclei Acids Res., 13, 1431-1442.
18. Funasaka Y, Boulton T, Cobb M, Yarden Y, Fan B, Lyman SD, Williams DE, Anderson DM, Zakut R, Mishima Y and Halaban R. (1992). Mol. Biol. Cell, 3, 197-209.
19. Gavrieli Y, Sherman Y and Ben-Sasson SA. (1992). J. Cell Biol., 119, 493-501.
20. Geissler EW, Ryan MA and Housman DE. (1988). Cell, 55, 185-192.
21. Giebel LB and Spritz RA. (1991). Proc. Natl. Acad. Sci. USA, 88, 8696-8699.
22. Grupposo PA, Mead JE and Fausto N. (1990). Cancer Res., 50, 1464-1469.
23. Gutman M, Singh RK, Radinsky R and Bar-Eli M. (1994). Anticancer Res., 14, 1759-1766.
24. Huang S, Singh RK, Xie K, Gutman M, Berry KK, Bucana CD, Fidler IJ and Bar-Eli M. (1994). Cancer Immunol. Immunother., 39, 231-238.
25. Kozlowski JM, Hart IR, Fidler IJ and Hanna N. (1984). J. Natl. Cancer Inst., 72, 913-917.
26. Lassam N and Bickford S. (1992). Oncogene, 7, 51-56.
27. Laster SM, Wood JC and Gooding LR. (1988). J. Immunol., 141, 2629-2634.
28. Lehmann JM, Reithmuller G and Johnson JP. (1989). Proc. Natl. Acad. Sci. USA, 86, 9891-9895.
29. Li L, Price JE, Fan D, Zhang RD, Bucana CD and Fidler IJ. (1989). J. Natl. Cancer Inst., 81, 1406-1412.
30. Longley BJ, Morganroth GS, Tyrrell L, Ding TG, Anderson DM, Williams DE and Halaban R. (1993). New Engl. J. Med., 328, 1302-1307.
31. Lu C and Kerbel RS. (1994). Curr. Opin. Oncol., 6, 212-220.
32. Lu C, Vickers MF and Kerbel RS. (1992). Proc. Natl. Acad. Sci. USA, 89, 9215-9219.
33. Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IJ and Bar-Eli M. (1993a). Melanoma Res., 3, 35-41.
34. Luca M, Lenzi R, Lee-Jackson D, Gutman M, Fidler IJ and Bar-Eli M. (1993b). Int. J. Oncol., 3, 19-22.
35. Luca M, Xie S, Gutman M, Huang S and Bar-Eli M. (1995). Oncogene, 11, 1399-1402.
36. McGregor BC, McGregor JL, Weiss LM, Wood GS, Chung-Hong H, Boukerche H and Warnke RA. (1989). Am. J. Clin. Pathol., 92, 495-499.
37. Mekori YA, Oh CK and Metcalfe DD. (1993). J. Immunol. 151, 3775-3784.
38. Miller AD and Rosman GJ. (1989). BioTechniques, 7, 980-990.
39. Miller AD, Trauber DR and Buttimore C. (1986). Somat. Cell Mol. Genet., 12, 175-181.
40. Morita E, Lee DG, Sugiyama M and Yamamoto S. (1994). Arch. Dermatol. Res., 286, 273-277.
41. Natali PG, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M and Ferrone S. (1990). Cancer Res., 50, 1271-1278.
42. Natali PG, Nicotra MR, Winkler AB, Cavaliere R, Bigotti A and Ullrich A. (1992). Int. J. Cancer, 52, 197-201.
43. Nishikawa S, Kusakabe M, Yoshinaga K, Ogawa M, Hayashi SI, Kunisada T, Era T, Sakakura T and Nishikawa SI. (1991). EMBO J., 10, 2111-2118.
44. Nocka K, Buck J, Levi E and Besmer P. (1990). EMBO J., 9, 3287-3294.
45. Nocka K, Majumder S, Chabot B, Ray P, Cervone M, Bernstein A and Besmer P. (1989). Genes Dev. 3, 816-826.
46. Qian F, Vaux DL and Weissman IL. (1994). Cell, 77, 335-347.
47. Radizadeh S, Oh J, Zhong LT, Bitler CM, Butcher LL and Bredesen DE. (1993). Science, 261, 345-348.
48. Radinsky R. (1991). Sem. Cancer Biol., 2, 169-177.
49. Radinsky R, Fidler IJ, Price JE, Esumi N, Tsan R, Petty CM, Bucana CD and Bar-Eli M. (1994). Oncogene, 9, 1977-1983.
50. Real FX, Rettig WJ and Chesa PF. (1986). Cancer Res., 46, 4726-4731.
51. Reith AD, Rottapel R, Giddens E, Brady C, Forrester L and Bernstein A. (1990). Genes Dev. 4, 390-400.
52. Schmid DA, Hornung R, McGrath KM, Paul N and Ruddle NH. (1987). Lymphokine Res., 6, 195-201.
53. Singh RK, Gutman M, Radinsky R, Bucana CD and Fidler IJ. (1994). Cancer Res., 54, 3242-3247.
54. Singh RK, Gutman M, Reich R and Bar-Eli M. (1995). Cancer Res., 55, 3669-3674.
55. Spritz RA, Giebel LB and Holmes SA. (1992). Am. J. Hum. Genet., 50, 261-269.
56. Tan JC, Nocka K, Ray P, Traktman P and Besmer P. (1990). Science, 247, 209-212.
57. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM and Kramer PH. (1989). Science, 245, 301-305.
58. Verschraegen CE, Giovanella BC, Mendoza JT, Kozielsky AI and Stehlin JS Jr. (1991). Anticancer Res., 11, 529-536.
59. Vile RG, Nelson JA, Castleden S, Chong H and Hart IR. (1994). Cancer Res., 54, 6228-6234.
60. Wilks AF. (1993). Adv. Cancer Res., 60, 43-73.
61. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Mumenitus S, Dull TJ, Chen E, Schlessinger J, Francke U and Ullrich A. (1987). EMBO J., 6, 3342-3351.
62. Yarden Y and Ullrich A. (1988). Ann. Rev. Biochem., 57, 443-478.
63. Zakut R, Perlis R, Eliyahu S, Yarden Y, Givol D, Lyman SD and Halaban R. (1993). Oncogene, 8, 2221-2229.
64. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ and Suggs S. (1990). Cell, 63, 213-224.